Paper Details

  1. Home
  2. Paper Details

Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.

Author: AcutoGiancarlo, AllaisGianni, BenedettoChiara, BussoneGennaro, D'AndreaGiovanni, GrazziLicia, ManzoniGian Camillo, MoschianoFranca, ValguarneraFabio, d'OnofrioFlorindo

Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Migraines are characterized by headaches and other symptoms, such as nausea, vomiting, sensitivity to light, sound, and smells, which affect quality of life. These symptoms are also common in migraines related to menstruation, a difficult-to-treat type of migraine. This study examined the effects of almotriptan on these migraine-associated symptoms (MAS) and found that it significantly reduced them compared to placebo over a 2-hour period.
Paper Details　
Original Abstract of the Article :
In addition to headache, migraine is characterized by a series of symptoms that negatively affects the quality of life of patients. Generally, these are represented by nausea, vomiting, photophobia, phonophobia and osmophobia, with a cumulative percentage of the onset in about 90% of the patients. F...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869014/

データ提供：米国国立医学図書館（NLM）

Menstrually Related Migraine: A Desert Storm of Discomfort

Imagine a desert oasis, a place of tranquility and respite. But what happens when a violent sandstorm suddenly sweeps through, disrupting the peaceful serenity? This is the experience of those suffering from menstrually related migraine, a debilitating condition that can strike with sudden and intense discomfort.

This study explores the effectiveness of almotriptan in treating migraine-associated symptoms (MAS) in menstrually related migraine, like finding a safe haven in the middle of a desert storm. The researchers, like meteorologists studying a storm's impact on a desert ecosystem, meticulously documented the effects of almotriptan on various MAS, providing valuable insights into the management of this challenging condition.

Almotriptan: A Powerful Oasis of Relief

The study found that almotriptan effectively reduced MAS, offering significant relief from nausea, vomiting, photophobia, phonophobia, and osmophobia, like a well-protected oasis providing shelter from the harsh desert elements. These findings suggest that almotriptan may be a valuable tool for managing the debilitating symptoms associated with menstrually related migraine.

Health Implications and Life Applications

This study offers hope for those suffering from menstrually related migraine, a potentially debilitating condition that can disrupt daily life. The findings suggest that almotriptan may be a valuable tool for managing the challenging symptoms associated with this condition, offering a more comfortable and manageable experience during the stormy periods.

Dr.Camel's Conclusion

Menstrually related migraine can be a violent desert storm, unleashing a torrent of discomfort and disrupting daily life. This study suggests that almotriptan, like a well-protected oasis, can provide significant relief from the challenging symptoms, offering a more comfortable and manageable experience during these turbulent periods.
Date :
  1. Date Completed 2010-08-17
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

20464599

DOI: Digital Object Identifier

PMC2869014

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.